← Back to Search

Dance Therapy for Neuropathy in Breast Cancer Survivors

N/A
Waitlist Available
Led By Lise Worthen-Chaudhari, PhD, MFA
Research Sponsored by Ohio State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Breast cancer survivor stage I-III
Symptomatic for neuropathy
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months post-intervention
Awards & highlights

Study Summary

This trial will study the effect of group dance classes on quality of life and physical health for cancer survivors.

Who is the study for?
This trial is for breast cancer survivors who have finished taxane-based chemotherapy at least 3 months ago, are experiencing neuropathy symptoms, and have balance issues. They must be able to follow study instructions. It's not for those with severe diabetes, vestibular deficits, lower limb amputations, or those in physical therapy.Check my eligibility
What is being tested?
The study tests the effects of group dance classes using Tango and rhythmic auditory stimulation on quality of life and physical health among breast cancer survivors suffering from neuropathy.See study design
What are the potential side effects?
While specific side effects aren't listed for dancing or rhythmic auditory stimulation, participants may experience fatigue or discomfort related to exercise. The social nature of tango could also affect emotional well-being positively or negatively.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am a breast cancer survivor of stage I, II, or III.
Select...
I experience symptoms of nerve damage.
Select...
My balance is poor and I'm middle-aged without a brain injury.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months post-intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months post-intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Secondary outcome measures
Brief Pain Inventory Short Form
Cancer-Related Fatigue
Clinical measure of balance function
+6 more
Other outcome measures
Quantified Clinical Measure of Balance Function

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: TangoExperimental Treatment1 Intervention
The intervention will consist of 16 Argentine Tango (Tango) sessions, adapted for neurorehabilitation per Hackney and Earhart (2010). Delivered over 8 weeks at a frequency of 2x per week and duration of 1 hour per session, this program teaches the basics steps of partnered Tango dance.
Group II: Home Exercise (HEX)Active Control1 Intervention
The control group will consist of an evidence-based, structured home exercise program (HEX) based on the 8 week intervention described by Zimmer et al (2018) and recommended by physical therapists specializing in BC within our organization. This program consists of information on neuropathy and fall prevention combined with a schedule of 1 hr training (i.e., endurance, resistance, and sensorimotor) performed 2x per week
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Rhythmic Auditory Stimulation
2018
N/A
~10

Find a Location

Who is running the clinical trial?

Ohio State UniversityLead Sponsor
827 Previous Clinical Trials
502,699 Total Patients Enrolled
9 Trials studying Breast Cancer
5,386 Patients Enrolled for Breast Cancer
Ohio State University Comprehensive Cancer CenterLead Sponsor
320 Previous Clinical Trials
290,115 Total Patients Enrolled
21 Trials studying Breast Cancer
2,832 Patients Enrolled for Breast Cancer
National Institute on Aging (NIA)NIH
1,668 Previous Clinical Trials
28,005,012 Total Patients Enrolled
13 Trials studying Breast Cancer
40,397 Patients Enrolled for Breast Cancer

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

To what extent is the research team expanding their cohort for this clinical trial?

"Affirmative. The clinicaltrials.gov site states that this medical trial, which was first posted on August 15th 2021, is still looking for participants. They require 52 individuals from a single location to take part in the study."

Answered by AI

Are there any available positions in this trial for participants?

"Affirmative. The information hosted on clinicaltrials.gov verifies that this trial, which was first announced 8/15/2021, is currently recruiting patients. This study is looking for 52 enrollees from a single medical centre."

Answered by AI
~14 spots leftby Apr 2025